PRESS RELEASE: Eqs-Adhoc: Merck Kgaa Confirms Discussions With Springworks Therapeutics, Inc. On Potential Acquisition

Dow Jones
11 Feb
EQS-Ad-hoc: Merck KGaA / Key word(s): Takeover 
Merck KGaA: Merck KGaA confirms discussions with Springworks Therapeutics, Inc. on potential acquisition 
10-Feb-2025 / 20:06 CET/CEST 
Disclosure of an inside information acc. to Article 17 MAR of the Regulation $(EU)$ No 596/2014, transmitted by EQS News 
- a service of EQS Group. 
The issuer is solely responsible for the content of this announcement. 
----------------------------------------------------------------------------------------------------------------------- 
Darmstadt, February 10, 2025 - Merck KGaA ("Merck") reacts to press reports and confirms advanced discussions with 
Springworks Therapeutics, Inc. Merck also confirms that no legally binding agreement has been entered into. There is no 
certainty that any transaction will materialize. Furthermore, critical conditions have yet to be met. 
End of inside information 
 
Contact Merck KGaA 
Dr. Gangolf Schrimpf 
Merck KGaA 
Frankfurter StraXXX223e 250 
64293 Darmstadt 
Germany 
Phone: +49 6151 729591 
Email: gangolf.schrimpf@merckgroup.com 
Internet: https://www.merckgroup.com/ 
ISIN: DE0006599905 
WKN: 659990 
Indices: DAX 
Stock exchanges: Regulated Market of Frankfurt am Main (Prime Standard); Open Markets of Berlin, Duesseldorf, Hamburg, 
Hanover, Munich, Stuttgart; EUREX derivatives exchange; London, SIX 
 
End of Inside Information 
----------------------------------------------------------------------------------------------------------------------- 
10-Feb-2025 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press 
Releases. 
Archive at www.eqs-news.com 
----------------------------------------------------------------------------------------------------------------------- 
Language:     English 
Company:      Merck KGaA 
              Frankfurter Str. 250 
              64293 Darmstadt 
              Germany 
Phone:        +49 (0)6151 72 - 2702 
E-mail:       insiderregister@merckgroup.com 
Internet:     https://www.merckgroup.com/de 
ISIN:         DE0006599905 
WKN:          659990 
Indices:      DAX 
Listed:       Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, 
              Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange; London, SIX 
EQS News ID:  2084015 
 
End of Announcement  EQS News Service 
------------- 

2084015 10-Feb-2025 CET/CEST

 

Image link: https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=show_t_gif&application_id=2084015&application_name=news&site_id=dow_jones%7e%7e%7e43f1f857-252a-44a4-bbde-f4a32f6a5492

 

(END) Dow Jones Newswires

February 10, 2025 14:08 ET (19:08 GMT)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10